The price gap between brand-name and compounded GLP-1s is staggering — often 5-10x. That gap is the single biggest driver of the compounded GLP-1 market, and it's the question every man starting GLP-1 therapy has to answer: do I pay $1,000+/month for brand-name, or $99-300/month for compounded?
What "Compounded" Actually Means
Compounded semaglutide is the same active molecule (semaglutide) prepared by a state-licensed compounding pharmacy rather than manufactured by Novo Nordisk. It's legally produced under Section 503A (individual prescriptions) or 503B (outsourcing facilities) of the Federal Food, Drug, and Cosmetic Act.
What it is: The same drug, prepared by licensed pharmacists, prescribed by licensed physicians. Legal when the brand-name is in shortage or when the compounded version is meaningfully different (e.g., different dosage form or combined with B12).
What it isn't: FDA-approved. Compounded medications don't go through the same approval process as brand-name drugs. They're regulated differently — by state pharmacy boards rather than by the full FDA approval pathway.
The Price Comparison
- Brand-name Wegovy (semaglutide): List price ~$1,349/month. With insurance: varies wildly ($0-500/month depending on plan). Without insurance: $1,000+ through manufacturer coupons and savings programs.
- Brand-name Zepbound (tirzepatide): List price ~$1,060/month. Similar insurance variability.
- Compounded semaglutide: $99-299/month depending on provider, dose, and plan structure.
- Compounded tirzepatide: $133-400/month depending on provider.
The math is simple: if you're paying cash without insurance, compounded saves you $700-1,200 per month. Over a year, that's $8,400-14,400.
Safety: What to Look For
Not all compounding pharmacies are created equal. The legitimate ones:
- 503B outsourcing facilities: Registered with FDA, subject to FDA inspection, follow current good manufacturing practices (cGMP). Higher standard.
- 503A pharmacies: Licensed by state pharmacy board, fill individual prescriptions, not FDA-inspected at the same frequency. Still legitimate but with more variability.
- LegitScript certified: Third-party certification that verifies pharmacy legitimacy. If a provider's pharmacy is LegitScript certified, it's a strong signal of legitimacy.
Red flags: No verifiable pharmacy license, no physician consultation required, prices too low to be real (below $80/month should raise questions), no patient intake process, ships without a prescription.
When Brand-Name Makes Sense
- Your insurance covers it with a reasonable copay
- You want the FDA-approved formulation with the exact clinical trial specifications
- Found Health and similar providers can coordinate insurance to get brand-name as low as $25/month
- You have a complex medical history and your physician specifically recommends the brand-name version
When Compounded Makes Sense
- No insurance coverage for brand-name GLP-1s (common — many plans still exclude them)
- Cash-pay patient and the $700+/month difference matters
- Provider uses 503B outsourcing facilities or LegitScript-certified pharmacies
- You've verified the provider's legitimacy through the criteria above
Sources
- FDA. Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
- Novo Nordisk. Wegovy list pricing. 2026.
- Eli Lilly. Zepbound list pricing. 2026.
- LegitScript. Pharmacy certification standards. legitscript.com.
- GobyMeds pricing. $99/mo semaglutide, $133/mo tirzepatide. Verified May 2026.